register

News & Trends - Pharmaceuticals

Pharmacy Guild supports real time monitoring of opioids

Health Industry Hub | February 10, 2020 |

The Pharmacy Guild of Australia welcomes the renewed push by Health Minister, Greg Hunt, to achieve a national system of real time opioid prescription monitoring by the end of 2020.

The Pharmacy Guild has long supported and called for the introduction of national real time recording of controlled drugs, a move which will benefit vulnerable patients and provide significant clinical decision-making support for doctors and pharmacists.

A national, uniform real-time monitoring system, will enable pharmacists to identify and support patients at risk of dependence and will also help to counter doctor shopping.

National President of the Pharmacy Guild of Australia, George Tambassis said: “We wholeheartedly welcome Minister Hunt’s declaration that real time recording across Australia is a matter of priority.

“Some States and Territories have already developed systems, but we need all jurisdictions on board and systems that talk to each other to ensure a nationally effective approach,” said Mr Tambassis.

“Victoria’s Safescript is evidence of the effectiveness of real time monitoring in reducing high-risk opioid doses. As a result of this program, high-risk opioid doses is reported to have decreased 25 per cent between April and October last year,” he said.

“Community pharmacists and the Guild stand ready to work with State and Territory Governments to make this a reality as soon as possible. We have to get this done,” Mr Tambassis said.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions developed by industry for industry.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

You may also like New PBS listings to bring hope for Australians living with kidney disease, cystic fibrosis and cancer


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.